Mastering the Art of Prescribing Serum and PRP Autologous Eye Drops

Cj Johnson
Feb 10, 2024
5 min read

Updated: Oct 13

Clinical Resource for Optometrists and Ophthalmologists

As an eye care specialist, the management of conditions like severe dry eye and refractory Meibomian Gland Dysfunction (MGD) demands advanced solutions. Autologous eye drops—specifically serum and PRP (Platelet-Rich Plasma) drops—represent the pinnacle of individualized regenerative care.

Understanding the core therapeutic mechanism and proper patient selection is essential to integrating this powerful tool effectively into your practice.

Understanding the Regenerative Mechanism

Autologous eye drops are formulated from the patient's own blood components (serum or plasma), offering a bespoke, preservative-free treatment that goes far beyond simple lubrication. They actively promote the healing and restoration of the ocular surface.

These drops are rich in crucial components that actively promote healing and restoration of the corneal epithelium.

Key Therapeutic Component	Primary Therapeutic Function
Epidermal Growth Factor (EGF)	Accelerates epithelial cell proliferation and migration; essential for rapid corneal healing.
Platelet-Derived Growth Factor (PDGF)	Potent mitogen promoting cellular growth and tissue repair.
Fibronectin	Acts as a natural scaffolding for epithelial cell adhesion and migration.
Vitamin A (Retinol)	Vital nutrient for maintaining the health of the ocular surface and goblet cell function.
Immunoglobulins & Antibodies	Provides natural, non-toxic defense against potential ocular surface infections.

By leveraging these concentrated growth factors and nutrients, autologous eye drops offer a superior, non-allergic treatment for patients who have not seen results from more conventional therapies.

Identifying Ideal Candidates For Prescribing Autologous Eye Drops: A Clinical Triage Checklist

The role of the healthcare provider goes beyond a simple prescription; it requires a detailed clinical assessment to identify appropriate candidates who will maximize the therapeutic benefit.

Ideal candidates often include patients with confirmed diagnoses such as:

Severe Systemic Disease: Sjögren's Syndrome, Graft-Versus-Host Disease (GVHD), or Stevens-Johnson Syndrome.
Ocular Surface Damage: Persistent Epithelial Defects (PEDs), Filamentary Keratitis, or Neurotrophic Keratopathy (NK).
Post-Surgical Complications: Chronic dry eye symptoms refractory to treatment after procedures like LASIK or cataract surgery.
Refractory MGD: Cases where traditional MGD treatments (LipiFlow, IPL, manual expression) have failed to restore adequate meibum production quality.
Preservative Intolerance: Patients who react negatively to traditional, preserved artificial or prescription tears.

Your understanding of the patient's medical history and their measured response to previous treatments (TBUT, OSDI scores, staining) is key in this decision-

making process.

Synergistic Therapies and Combined Protocols

For optimal, long-term patient outcomes, autologous drops should often be viewed not as a standalone solution, but as an essential regenerative maintenance phase following in-office procedures.

Maximizing Thermal/Mechanical Therapies (IPL & LipiFlow)

Therapies like Intense Pulsed Light (IPL) and LipiFlow are highly effective at clearing blockages and restoring meibum flow. However, they do not inherently heal the chronic damage to the ocular surface and meibomian glands caused by inflammation and dry eye disease.

The Problem: Without concentrated growth factors, the cleared glands and damaged corneal tissue are prone to rapid regression and re-inflammation.
The Solution: Prescribing PRP/Serum Drops immediately following IPL or LipiFlow provides the necessary biological components to actively heal the underlying cellular damage, promoting sustainable function and protecting the patient’s significant financial investment in the procedure. This is the Gold Standard Combined Approach.

Synergy with Punctal Plugs

Punctal plugs are a mechanical solution designed to retain the patient's existing tears. However, if the retained tears are of low quality (lacking growth factors and nutrients), simply preserving them is often insufficient for severe ocular surface disease.

The Problem: Plugging a drain doesn't fix a broken pipe. Retaining poor-quality tears can sometimes increase the concentration of inflammatory markers.
The Solution: Combining plugs with PRP/Serum drops ensures that the preserved tear film is now enriched with concentrated, regenerative factors. This transforms the retained fluid from a low-quality inflammatory medium into a high-quality healing medium, leading to superior clinical results.

A smiling ophthalmologist or optometrist in a lab coat standing in a modern clinic, representing the professional who provides a detailed clinical assessment for patient treatments. — Renowned ophthalmologist confidently posing in a modern medical office, ready to provide expert eye care.

The Prescription Process: A 3-Step Collaborative Flow

Prescribing autologous eye drops involves a collaborative, streamlined effort between you, the patient, and a specialized compounding/concierge company like Enrich.

Step 1: Clinical Decision & Prescription (Your Role)

Patient Identification: Select a suitable candidate based on the clinical checklist above.
Concentration: The initial prescription concentration is crucial.
- Serum Tears: Advise beginning with 50% to 75% concentration for a balanced therapeutic effect.
- PRP Eye Drops: We recommend a 100% concentration to maximize the delivery of growth factors for significant tissue regeneration.
- Follow-Up: Adjust concentration for subsequent batches based on objective clinical response.
Dosage: Prescribe the frequency and duration of use.

Step 2: Concierge Collection & Compounding (Enrich's Role)

In-Home Mobile Collection: Our licensed Registered Nurses (RNs) or technicians travel to the patient's location for a comfortable, professional blood draw. We never outsource this critical step.
Compounding Process: The sample undergoes strict, sterile centrifugation to separate the plasma/serum. The rich component is then diluted (if required), filtered for sterility, and compounded into individual vials.

Step 3: Hand Delivery & Patient Adherence

Guaranteed Delivery: The final eye drop vials are carefully packaged and hand-delivered with clinical precision directly to the patient by our dedicated team—ensuring guaranteed quality and consistency.

Best Practices for Patient Adherence

The success of regenerative therapy is highly dependent on patient understanding and consistency. Provide the following clinical guidance:

Patient Education Topic	Key Talking Points
Setting Expectations	This is a customized treatment, not a quick fix. Relief may begin within the first week, but full therapeutic effect may take 1-2 months. Patience and consistent use are non-negotiable.
Storage & Handling	Refrigeration is mandatory to maintain efficacy. Once a vial is thawed, it must be used within one week to minimize the risk of bacterial contamination.
Addressing Cost	Clearly explain that these are often not covered by insurance. Emphasize that the cost is an investment in a bespoke, preservative-free solution that aims for long-term healing, reducing the need for continuous, ineffective OTC treatments.
Monitoring Progress	Reinforce the importance of regular follow-ups to monitor progress using objective metrics (TBUT, OSDI, staining) to guide prescription adjustment.

The Enrich Concierge Advantage: Why Partner With Us

When you refer your patients to Enrich, you are joining a network committed to clinical excellence and concierge convenience, ensuring a seamless experience for your practice and your patient:

Integrated Care: We coordinate all logistics with your office, ensuring the prescription is accurate and the patient's journey is smooth.
In-House Mobile Collection: Every collection is performed by our own trusted RNs and technicians—we never outsource this patient-facing step.
Guaranteed Quality: All compounding and delivery are handled by our dedicated in-house team, ensuring the highest standards of sterility and consistent quality from our processing center directly to your patient.

In the evolving landscape of ophthalmology, autologous eye drops signify a revolutionary step towards individualized treatment. Mastery over prescribing them is attained through clinical excellence and partnering with reliable logistics.

➡️ Request Your Free Physician Starter Kit